Alyeska Investment Group’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,285	Closed	-$999K	–	588
2024 Q1	$999K	Sell	71,285 -163,333	-70%	-$2.29M	0.01%	395
2023 Q4	$1.99M	Buy	234,618 +145,837	+164%	+$1.24M	0.01%	349
2023 Q3	$793K	Buy	+88,781	New	+$793K	0.01%	413